HIF1A and colorectal cancer: In an in vitro experiment, we demonstrated that hypoxia-inducible factor 1α (HIF-1α), which was induced in this hypoxic environment, prevented cell death and promoted the therapeutic resistance of colorectal cancer cells [29].